Lisata Therapeutics, Inc. Share Price
NASDAQ: LSTA | Micro CapLisata Therapeutics, Inc. Stock Performance
Lisata Therapeutics, Inc. Share Price Today
As of 19 September 2026, Lisata Therapeutics, Inc.'s share price is $1.70. The stock opened at $1.73, compared to its previous close of $1.72. During today's trading session, Lisata Therapeutics, Inc.'s share price traded between $1.63 and $1.74, with an average price of $1.69. Over the past 52 weeks, the stock has recorded a high of $5.07 and a low of $0.99. In terms of performance, Lisata Therapeutics, Inc.'s share price has declined by 66.14% over the last six months and is down 33.33% on a year-on-year basis.
Lisata Therapeutics, Inc. Share Price Chart
Lisata Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Lisata Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Lisata Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $1.51 | $1.65 | -11.76% |
Aug 2026 | $1.05 | $1.87 | +78.10% |
Jul 2026 | $3.40 | $1.05 | -69.21% |
Jun 2026 | $3.60 | $3.41 | +7.23% |
May 2026 | $3.26 | $3.18 | -0.63% |
Apr 2026 | $5.01 | $3.20 | -36.25% |
Mar 2026 | $4.27 | $5.02 | +20.38% |
Feb 2026 | $4.60 | $4.17 | -8.65% |
Jan 2026 | $1.93 | $4.57 | +145.43% |
Dec 2025 | $1.95 | $1.86 | -9.49% |
Nov 2025 | $2.66 | $2.06 | -26.08% |
Oct 2025 | $2.41 | $2.78 | +9.02% |